Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
9,335
Total Claims
$1.2M
Drug Cost
750
Beneficiaries
$1,580
Cost/Patient
Risk Score Breakdown 21/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
+311%
Opioid rate vs peers
10.6% vs 2.6% avg
+48%
Cost per patient vs peers
$1,580 vs $1,068 avg
+54%
Brand preference vs peers
13.9% vs 9.0% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
Opioid rate is 311% above Family Practice peers. This is a significant deviation that may reflect a specialized patient population or concerning prescribing patterns.
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
10.6%
Opioid Rate
990
Opioid Claims
$35K
Opioid Cost
5.3%
Long-Acting Rate
Brand vs Generic
Brand: 1,290 claims · $961K
Generic: 8,000 claims · $221K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Semaglutide | 159 | $177K |
| Dulaglutide | 128 | $149K |
| Apixaban | 82 | $73K |
| Empagliflozin | 55 | $50K |
| Sacubitril/Valsartan | 41 | $47K |
| Tirzepatide | 25 | $35K |
| Rivaroxaban | 45 | $31K |
| Mirabegron | 39 | $29K |
| Fluticasone/Umeclidin/Vilanter | 32 | $26K |
| Finerenone | 22 | $18K |
| Insulin Glargine,hum.Rec.Anlog | 28 | $17K |
| Erenumab-Aooe | 21 | $17K |
| Sitagliptin Phosphate | 15 | $15K |
| Hydrocodone/Acetaminophen | 456 | $14K |
| Cyclosporine | 13 | $10K |
Prescribing Profile
Patient Profile
74
Avg Age
55%
Female
1.51
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data